Cell-penetrating peptides as a gateway for nanocarrier-mediated glioblastoma therapy
Authors:
- Aditi SononeASAditi Sonone
- Mansi ThakurMTMansi Thakur
- Sagar TrivediSTSagar Trivedi
- Sapna PatelSPSapna Patel
- Manisha KawadkarMKManisha Kawadkar
- Kamlesh WadherKWKamlesh Wadher
Open Access
- 1 June 2026
- journal article
- Published by KEAI Publishing in Precision Medication
- Vol. 3 (2)
Abstract
No abstract availableThis publication has 81 references indexed in Scilit:
- Amphipathic Octenyl‐Alanine Modified Peptides Mediate Effective siRNA DeliveryJournal of Peptide Science, 2025
- Peptide drug delivery: Permeation behaviour and intracellular fate of hydrophobic ion pairs in self-emulsifying drug delivery systemsEuropean Journal of Pharmaceutical Sciences, 2025
- Adult glioblastoma in England: Incidence, treatment, and outcomes with novel population-based strataCancer Epidemiology, 2025
- Directed discovery of high-loading nanoaggregates enabled by drug-matched oligo-peptide excipientsChem, 2025
- Advanced imaging reveals enhanced malignancy in glioblastomas involving the subventricular zone: evidence of increased infiltrative growth and perfusionJournal of Neuro-Oncology, 2024
- Tumor microenvironment-responsive cell-penetrating peptides: Design principle and precision deliveryColloids and Surfaces B: Biointerfaces, 2024
- Fabrication and optimization of chitosan-g-m-PEG-NH2 copolymer for advanced glioblastoma therapy using surface engineered lentinan loaded nanovesicles for nasal deliveryInternational Journal of Biological Macromolecules, 2024
- Inside Cover: Engineered Histidine‐Rich Peptides Enhance Endosomal Escape for Antibody‐Targeted Intracellular Delivery of Functional Proteins (Angew. Chem. Int. Ed. 38/2023)Angewandte Chemie International Edition, 2023
- Development and Validation of a UV Spectrophotometric Method for the Estimation of the Synthesized Lentinan–Congo Red ComplexJournal of Applied Spectroscopy, 2022
- Temozolomide resistance in glioblastoma multiformeGenes & Diseases, 2016